Accumulating evidence suggests that FDX1 mutations result in permanent neonatal diabetes with subclinical exocrine deficiency35, while DLAT mutations cause atypical Pantothenate Kinase Associated Neurodegeneration (PKAN)36. Here, DLAT is linked to diabetes mellitus.